These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lung microbiology and exacerbations in COPD. Beasley V; Joshi PV; Singanayagam A; Molyneaux PL; Johnston SL; Mallia P Int J Chron Obstruct Pulmon Dis; 2012; 7():555-69. PubMed ID: 22969296 [TBL] [Abstract][Full Text] [Related]
23. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease. Alikhan MM; Lee FE Curr Opin Pulm Med; 2014 Mar; 20(2):159-64. PubMed ID: 24441573 [TBL] [Abstract][Full Text] [Related]
24. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient. Murphy TF; Sethi S Drugs Aging; 2002; 19(10):761-75. PubMed ID: 12390053 [TBL] [Abstract][Full Text] [Related]
25. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Sethi S; Murphy TF Clin Microbiol Rev; 2001 Apr; 14(2):336-63. PubMed ID: 11292642 [TBL] [Abstract][Full Text] [Related]
26. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. De Serres G; Lampron N; La Forge J; Rouleau I; Bourbeau J; Weiss K; Barret B; Boivin G J Clin Virol; 2009 Oct; 46(2):129-33. PubMed ID: 19665425 [TBL] [Abstract][Full Text] [Related]
27. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA; Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298 [TBL] [Abstract][Full Text] [Related]
29. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease. Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905 [TBL] [Abstract][Full Text] [Related]
30. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease]. Targowski T; Jahnz-Rózyk K Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344 [TBL] [Abstract][Full Text] [Related]
31. Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples. Alotaibi NM; Chen V; Hollander Z; Leipsic JA; Hague CJ; Murphy DT; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD Int J Chron Obstruct Pulmon Dis; 2019; 14():311-319. PubMed ID: 30774328 [TBL] [Abstract][Full Text] [Related]
32. Role of infections. Rangelov K; Sethi S Clin Chest Med; 2014 Mar; 35(1):87-100. PubMed ID: 24507839 [TBL] [Abstract][Full Text] [Related]
33. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease. Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638 [TBL] [Abstract][Full Text] [Related]
34. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Diederen BM; van der Valk PD; Kluytmans JA; Peeters MF; Hendrix R Eur Respir J; 2007 Aug; 30(2):240-4. PubMed ID: 17459899 [TBL] [Abstract][Full Text] [Related]
35. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Hewitt R; Farne H; Ritchie A; Luke E; Johnston SL; Mallia P Ther Adv Respir Dis; 2016 Apr; 10(2):158-74. PubMed ID: 26611907 [TBL] [Abstract][Full Text] [Related]
36. Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. Andreas S; Testa M; Boyer L; Brusselle G; Janssens W; Kerwin E; Papi A; Pek B; Puente-Maestu L; Saralaya D; Watz H; Wilkinson TMA; Casula D; Di Maro G; Lattanzi M; Moraschini L; Schoonbroodt S; Tasciotti A; Arora AK; Maltais F; Lancet Respir Med; 2022 May; 10(5):435-446. PubMed ID: 35026180 [TBL] [Abstract][Full Text] [Related]
38. [Bacterial flora in acute exacerbations of chronic obstructive pulmonary disease (COPD) in Kunming, China]. Yang X; Strobel M; Tian L; Barennes H; Buisson Y Med Mal Infect; 2011 Apr; 41(4):186-91. PubMed ID: 21195565 [TBL] [Abstract][Full Text] [Related]
39. Streptococcus pneumoniae urinary antigen test and acute exacerbations of chronic obstructive pulmonary disease. Nishimura K; Nishimura T; Oga T COPD; 2012 Aug; 9(4):344-51. PubMed ID: 22452423 [TBL] [Abstract][Full Text] [Related]
40. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Bouquet J; Tabor DE; Silver JS; Nair V; Tovchigrechko A; Griffin MP; Esser MT; Sellman BR; Jin H Respir Res; 2020 Mar; 21(1):77. PubMed ID: 32228581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]